Results 271 to 280 of about 256,425 (387)

Circulating miR-223-3p as an Independent Biomarker of Recurrent Thrombotic Risk After Ischemic Stroke. [PDF]

open access: yesBiomedicines
Balczó B   +9 more
europepmc   +1 more source

Advances in emerging therapies 2008 [PDF]

open access: yes, 2009
Higgins, P., Lees, K.R.
core   +1 more source

Long‐term stability of sinus complication management

open access: yesPeriodontology 2000, EarlyView.
Abstract Maxillary sinus augmentation shows a low incidence of complications and high clinical success due to favorable biological conditions and typically transient issues. Most complications are intraoperative, such as Schneiderian membrane perforation or hemorrhage, and are often resolved immediately.
Pablo Galindo‐Moreno   +5 more
wiley   +1 more source

Antithrombotic therapy in lower extremity peripheral artery disease patients with venous thromboembolism: a nationwide cohort study. [PDF]

open access: yesRes Pract Thromb Haemost
Goedegebuur J   +11 more
europepmc   +1 more source

Perinatal clinical management of a rare ABh variant blood group

open access: yesTransfusion Medicine, EarlyView.
Abstract Background The H antigen, precursor of the A and B blood groups, is a high‐prevalence antigen. Very few H antigen‐negative (H−) blood donors are available in the United Kingdom. Case Presentation We present the case of a second pregnancy in a 28‐year‐old woman with the very rare ABh phenotype, and the presence of anti‐H, anti‐A and anti‐B ...
Aritri Mandal   +4 more
wiley   +1 more source

Effect of Antiplatelet Therapy (Aspirin + Dipyridamole Versus Clopidogrel) on Mortality Outcome in Ischemic Stroke

open access: green, 2018
Raphae S. Barlas   +9 more
openalex   +2 more sources

An audit of platelet transfusions at a tertiary care center: New opportunities for patient blood management with the 2025 AABB/ICTMG platelet guidelines

open access: yesTransfusion, EarlyView.
Abstract Background Platelet transfusions are an important tool to prevent and stop bleeding. Thresholds for pretransfusion platelet counts have been studied in various patient populations, yielding evidence‐based guidelines. The Association for the Advancement of Blood and Biotherapies (AABB) collaborated with the International Collaboration for ...
Rylee Yakymi, Claudia S. Cohn
wiley   +1 more source

Home - About - Disclaimer - Privacy